Benacerraf A, Veron P, Morin B, Castillo-Fenoy A, Chapuis A, Ziskind B
Nouv Presse Med. 1977 Jan;6(1):22-6.
The authors report the cases of three women aged 23, 24 and 28 years, receiving oestro-progestational agents and suffering a myocardial infarction. 25 cases in the literature are reviewed. Infarction is in most cases the first symptom. The clinical picture has no special features other than the frequency of anterior localisations. Coronary arteriography carried out in 15 cases showed a lesion of one vessel in 10 patients. The most common finding was a thrombosis of the left anterior descending. The coronaries were almost of completely normal in 3 cases, diffuse lesions being found only in 2 patients. The long term prognosis, at first sight favourable since the problem is one of localised lesions, is worsened by the frequency of ventricular contraction abnomalities. Myocardial infarction in patients taking oestro-progestational agents remains rare. A logical hypothesis to explain it would be a synergistic effect between the hypercoagulability induced by the drug and the risk factors in the individual patient. They are present with a frequency similar to that seen in other series of young patients with coronary disease.
作者报告了3名年龄分别为23岁、24岁和28岁的女性病例,她们在服用雌孕激素制剂时发生了心肌梗死。对文献中的25个病例进行了回顾。在大多数情况下,梗死是首发症状。除了前壁定位的频率较高外,临床表现没有其他特殊特征。15例患者进行的冠状动脉造影显示,10例患者有单支血管病变。最常见的发现是左前降支血栓形成。3例患者的冠状动脉几乎完全正常,仅2例患者发现弥漫性病变。乍一看,长期预后似乎良好,因为问题是局限性病变之一,但心室收缩异常的频率会使预后恶化。服用雌孕激素制剂的患者发生心肌梗死仍然很少见。一个合理的解释假设是药物诱导的高凝状态与个体患者的危险因素之间存在协同作用。这些危险因素的出现频率与其他年轻冠心病患者系列中所见相似。